Diversified’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$3.5M Sell
3,948
-1
-0% -$899 0.38% 20
2024
Q2
$3.58M Buy
3,949
+3,174
+410% +$2.54M 0.42% 19
2024
Q1
$603K Sell
775
-186
-19% -$132K 0.08% 72
2023
Q4
$560K Buy
961
+71
+8% +$41.4K 0.12% 70
2023
Q3
$478K Buy
890
+10
+1% +$5.15K 0.12% 73
2023
Q2
$413K Hold
880
0.11% 83
2023
Q1
$302K Sell
880
-915
-51% -$309K 0.11% 107
2022
Q4
$657K Buy
1,795
+1,047
+140% +$371K 0.26% 57
2022
Q3
$242K Buy
748
+1
+0.1% +$317 0.12% 102
2022
Q2
$242K Hold
747
0.1% 88
2022
Q1
$214K Buy
+747
New +$192K 0.09% 111
2021
Q1
Sell
-666
Closed -$99K 220
2020
Q4
$99K Buy
+666
New +$99.4K 0.08% 141

Other funds holding LLY

Diversified's LLY Position: Q3 2024 in Review

Diversified reduced its Eli Lilly (LLY) stake by 0.03% in Q3 2024, selling an estimated $899 and leaving 3,948 shares worth $3.5M. The position accounts for 0.38% of the portfolio, ranked #20.

Diversified first reported a position in LLY in Q4 2020 and has held it in 12 quarters since. The position peaked at $3.58M in Q2 2024. 3,659 funds tracked by Wall St. Rank hold LLY as of Q3 2024.

  • Diversified held 3,948 shares of Eli Lilly worth $3.5M as of Q3 2024.
  • Diversified sold 1 Eli Lilly share in Q3 2024, an estimated $899.
  • Eli Lilly made up 0.38% of Diversified's portfolio in Q3 2024, its #20 holding.
  • Diversified first reported a position in Eli Lilly in Q4 2020 and has held it in 12 quarters since.
  • Diversified's Eli Lilly position peaked at $3.58M in Q2 2024.
  • 3,659 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2024.

Based on Diversified's 13F filing for Q3 2024, filed 13 Nov 2024.